Authors: WICKRAMANAVAKE PD STEINMETZ HT KATAY I GLASMACHER A NEUFANG A STAIB P SCHWONZEN M DIEHL V

Citation: Pd. Wickramanavake et al., PHASE-II TRIAL OF IDARUBICIN, FLUDARABINE, CYTIDINE ARABINOSIDE (ARA-C), AND FILGRASTIM (G-CSF) (IDA-FLAG) FOR TREATMENT OF POOR-PROGNOSIS ACUTE MYELOID-LEUKEMIA (AML), Blood, 84(10), 1994, pp. 10000618-10000618